The Continence Aids Payment Scheme Amendment (Eligibility) Instrument 2022 changed who can get payments under the Continence Aids Payment Scheme (CAPS) to avoid double-dipping. It means that care recipients who already receive continence products as part of a residential care service are not eligible for additional payments under the CAPS.
The analyst's Rx/Reimbursement adult incontinence in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2027 illustrate how the market is set to change.
Data Coverage
Market Sizes(historic and forecasts), company shares, brand shares and distribution data.
The analyst's Rx/Reimbursement adult incontinence in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2027 illustrate how the market is set to change.
Data Coverage
Market Sizes(historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Rx/Reimbursement adult incontinence market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
RX/REIMBURSEMENT ADULT INCONTINENCE IN AUSTRALIAKEY DATA FINDINGS
2022 DEVELOPMENTS
- The Continence Aids Payment Scheme amends the eligibility criteria in 2022
- Call for transparency in the Continence Aids Payment Scheme
- Government scheme in Victoria excludes disposable pads/pants
- Ageing demographic and policy outlook poised to stimulate growth
- Shift to retail purchases of adult incontinence products
- Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2017-2022
- Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2017-2022
- Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2022-2027
- Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2022-2027
EXECUTIVE SUMMARY
- Tissue and hygiene in 2022: The big picture
- Competitive landscape
- Retailing developments
- What next for tissue and hygiene?
- Table 5 Birth Rates 2017-2022
- Table 6 Infant Population 2017-2022
- Table 7 Female Population by Age 2017-2022
- Table 8 Total Population by Age 2017-2022
- Table 9 Households 2017-2022
- Table 10 Forecast Infant Population 2022-2027
- Table 11 Forecast Female Population by Age 2022-2027
- Table 12 Forecast Total Population by Age 2022-2027
- Table 13 Forecast Households 2022-2027
- Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2017-2022
- Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2017-2022
- Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2018-2022
- Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2019-2022
- Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2017-2022
- Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2017-2022
- Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2022
- Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2022-2027
- Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2022-2027
SOURCES
- Summary 1 Research Sources
